Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other Accumulated Expenses (2016 - 2023)

Editas Medicine (EDIT) has disclosed Other Accumulated Expenses for 9 consecutive years, with $78000.0 as the latest value for Q2 2023.

  • Quarterly Other Accumulated Expenses fell 97.18% to $78000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $78000.0 through Jun 2023, down 97.18% year-over-year, with the annual reading at $1.6 million for FY2022, 16.12% up from the prior year.
  • Other Accumulated Expenses for Q2 2023 was $78000.0 at Editas Medicine, down from $109000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $4.0 million in Q2 2020, with the low at $78000.0 in Q2 2023.
  • Average Other Accumulated Expenses over 5 years is $1.2 million, with a median of $862000.0 recorded in 2021.
  • The sharpest move saw Other Accumulated Expenses surged 1612.09% in 2019, then crashed 97.18% in 2023.
  • Over 5 years, Other Accumulated Expenses stood at $599000.0 in 2019, then surged by 88.65% to $1.1 million in 2020, then rose by 24.6% to $1.4 million in 2021, then rose by 16.12% to $1.6 million in 2022, then crashed by 95.23% to $78000.0 in 2023.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $78000.0, $109000.0, and $1.6 million for Q2 2023, Q1 2023, and Q4 2022 respectively.